Business Description
Corline Biomedical AB
ISIN : SE0006887451
Compare
Compare
Traded in other countries / regions
CLBIO.Sweden IPO Date
2015-06-03Description
Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 9.02 | |||||
| Beneish M-Score | -4.08 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 73.3 | |||||
| 3-Year EBITDA Growth Rate | 43.7 | |||||
| 3-Year EPS without NRI Growth Rate | 43.3 | |||||
| 3-Year FCF Growth Rate | 18.6 | |||||
| 3-Year Book Growth Rate | 15.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.14 | |||||
| 9-Day RSI | 49.75 | |||||
| 14-Day RSI | 45.57 | |||||
| 6-1 Month Momentum % | -31.61 | |||||
| 12-1 Month Momentum % | -37.98 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.14 | |||||
| Quick Ratio | 1.14 | |||||
| Cash Ratio | 0.86 | |||||
| Days Sales Outstanding | 68.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.7 | |||||
| Shareholder Yield % | -0.14 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 137.11 | |||||
| Operating Margin % | -68.68 | |||||
| Net Margin % | -68.77 | |||||
| FCF Margin % | -70.61 | |||||
| ROE % | -10.68 | |||||
| ROA % | -9.73 | |||||
| ROIC % | -11.28 | |||||
| ROC (Joel Greenblatt) % | -3287.96 | |||||
| ROCE % | -10.66 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 1.13 | |||||
| PS Ratio | 10.43 | |||||
| PB Ratio | 1.7 | |||||
| Price-to-Tangible-Book | 95.71 | |||||
| EV-to-EBIT | -16.31 | |||||
| EV-to-Forward-EBIT | -85.31 | |||||
| EV-to-EBITDA | -16.46 | |||||
| EV-to-Forward-EBITDA | -85.31 | |||||
| EV-to-Revenue | 11.2 | |||||
| EV-to-Forward-Revenue | 5.56 | |||||
| EV-to-FCF | -15.6 | |||||
| Price-to-Net-Current-Asset-Value | 111.67 | |||||
| Earnings Yield (Greenblatt) % | -6.13 | |||||
| FCF Yield % | -6.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Corline Biomedical AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 14.007 | ||
| EPS (TTM) (kr) | -0.44 | ||
| Beta | 0.43 | ||
| Volatility % | 44.09 | ||
| 14-Day RSI | 45.57 | ||
| 14-Day ATR (kr) | 0.567957 | ||
| 20-Day SMA (kr) | 6.755 | ||
| 12-1 Month Momentum % | -37.98 | ||
| 52-Week Range (kr) | 5.98 - 16.8 | ||
| Shares Outstanding (Mil) | 24.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Corline Biomedical AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Corline Biomedical AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Corline Biomedical AB Frequently Asked Questions
What is Corline Biomedical AB(OSTO:CLBIO)'s stock price today?
The current price of OSTO:CLBIO is kr6.70. The 52 week high of OSTO:CLBIO is kr16.80 and 52 week low is kr5.98.
When is next earnings date of Corline Biomedical AB(OSTO:CLBIO)?
The next earnings date of Corline Biomedical AB(OSTO:CLBIO) is 2025-02-17.
Does Corline Biomedical AB(OSTO:CLBIO) pay dividends? If so, how much?
Corline Biomedical AB(OSTO:CLBIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers